Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,489 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06523374 | A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer(Endeavor-1) | recruiting | N/A | 50 | University Hospital, AntwerpOTHER | 6 | Feb 24, 2026 | clinicaltrials |
| NCT07429851 | CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors(LINEAR) | recruiting | — | 34 | European Institute of Oncology |
| 1 |
| Feb 24, 2026 |
| clinicaltrials |
| NCT07429864 | Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide(Bio-Delta) | recruiting | — | 20 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT06446882 | Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer(DEFINITIVE) | recruiting | N/A | 304 | Fundacio Clinic BarcelonaOTHER | 5 | Feb 20, 2026 | clinicaltrials |
| NCT06877949 | FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer(MONITOR-RCT) | recruiting | N/A | 420 | Odense University HospitalOTHER | 3 | Feb 20, 2026 | clinicaltrials |
| NCT07089550 | PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)(PELICAN) | recruiting | — | 1,300 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT06878469 | SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence(SIMPLIF-AI) | recruiting | N/A | 200 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07419893 | Germline Genetic Testing of the TP53 Gene | recruiting | — | 1,940 | European Institute of OncologyOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT04202341 | Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) | recruiting | — | 500 | Alexion Pharmaceuticals, Inc.INDUSTRY | 7 | Feb 18, 2026 | clinicaltrials |
| NCT04833894 | Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis(ADAPT Jr) | recruiting | Phase 2 / Phase 3 | 12 | argenxINDUSTRY | 12 | Feb 18, 2026 | clinicaltrials |
| NCT05879757 | Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency | recruiting | — | 75 | TakedaINDUSTRY | 11 | Feb 18, 2026 | clinicaltrials |
| NCT07416513 | Digital Solutions for bEtter cAre(ALTHEA) | recruiting | N/A | 200 | European Institute of OncologyOTHER | 5 | Feb 18, 2026 | clinicaltrials |
| NCT07417072 | GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients | recruiting | N/A | 50 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07417085 | MICRO-BRAIN 2024: Study on Pediatric Brain Tumors | recruiting | N/A | 100 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07419178 | A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept(GR-MPN) | recruiting | N/A | 265 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT06298565 | A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa | recruiting | — | 680 | argenxINDUSTRY | 6 | Feb 17, 2026 | clinicaltrials |
| NCT06830759 | Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma(EpcoReal) | recruiting | — | 700 | AbbVieINDUSTRY | 13 | Feb 17, 2026 | clinicaltrials |
| NCT07403630 | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)(IT-TCP POS) | recruiting | N/A | 300 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407465 | Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.(CHIMERA) | recruiting | Phase 2 | 42 | Gruppo Oncologico del Nord-OvestOTHER | 4 | Feb 17, 2026 | clinicaltrials |
| NCT07412782 | REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) | recruiting | N/A | 100 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07415499 | Breast Density Impact on Mammographic Screening for Breast Cancer Diagnosis(SINATRA) | recruiting | — | 3,300 | Azienda Sanitaria Locale CN2 Alba-BraOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT05544019 | Study of SGR-1505 in Mature B-Cell Neoplasms | recruiting | Phase 1 | 98 | Schrödinger, Inc.INDUSTRY | 8 | Feb 13, 2026 | clinicaltrials |
| NCT05448365 | Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid | recruiting | N/A | 60 | Lo.Li.Pharma s.r.lINDUSTRY | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06805734 | Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants(PTEN_Ped) | recruiting | — | 50 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07397624 | Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer(ESG-ENDO) | recruiting | — | 74 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07401615 | Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions | recruiting | — | 150 | Istituto Clinico HumanitasOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07407608 | ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0(ABRUPT 2) | recruiting | — | 58 | University of Milano BicoccaOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06071286 | SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS(SPEED) | recruiting | N/A | 30 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06610565 | Fasting-mimicking Diet Intervention on Side Effects of Aromatase Inhibitors Treatment in Patients With Breast Cancer | recruiting | N/A | 60 | European Institute of OncologyOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06723990 | Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX(HER2BREASTDX) | recruiting | — | 60 | European Institute of OncologyOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06844838 | FASt Track in Elective Neurosurgery: the Role of Low Propofol Bis-NOL Guided General Anaesthesia for Full, Early and Safe Awakening(FasTrack) | recruiting | — | 100 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07233954 | Intraoperative Use of I.V. Sodium Fluorescein in Suspected CNS Tumors(FLUOCERTUM) | recruiting | — | 100 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT07250750 | A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis(Synergy-MG) | recruiting | Phase 1 / Phase 2 | 96 | ImmunAbs Inc.INDUSTRY | 6 | Feb 11, 2026 | clinicaltrials |
| NCT07397585 | stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database(ORIETTA) | recruiting | — | 300 | Istituto Clinico HumanitasOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06435429 | A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer | recruiting | Phase 3 | 550 | Jazz PharmaceuticalsINDUSTRY | 15 | Feb 10, 2026 | clinicaltrials |
| NCT07399808 | CDK4/6 Inhibitors in Breast Cancer Elderly Patients: an Observational Ambispective Longitudinal Multicenter Study | recruiting | — | 100 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT04895436 | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)(ReVenG) | recruiting | Phase 2 | 75 | AbbVieINDUSTRY | 11 | Feb 9, 2026 | clinicaltrials |
| NCT06748001 | Avapritinib Rollover Study | recruiting | Phase 4 | 60 | Blueprint Medicines CorporationINDUSTRY | 6 | Feb 9, 2026 | clinicaltrials |
| NCT07396896 | KETO-TUMOR: a Study on Brain Tumors and Central Obesity | recruiting | N/A | 30 | Meyer Children's Hospital IRCCSOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06127407 | Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen(CHONQUER) | recruiting | Phase 3 | 136 | Servier Bio-Innovation LLCINDUSTRY | 17 | Feb 6, 2026 | clinicaltrials |
| NCT07392658 | Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.(AMICUTE) | recruiting | Phase 2 | 33 | Fondazione Ricerca TraslazionaleOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT06967480 | Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis | recruiting | — | 40 | Alexion Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07389265 | Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer(CAPRI-3 GOIM) | recruiting | Phase 3 | 480 | University of Campania Luigi VanvitelliOTHER | 2 | Feb 5, 2026 | clinicaltrials |
| NCT05779670 | Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery(ADER) | recruiting | — | 50 | Istituto Ortopedico RizzoliOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06697197 | A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 413 | Bristol-Myers SquibbINDUSTRY | 9 | Feb 3, 2026 | clinicaltrials |
| NCT07278921 | Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP).(MosuOSSHSR) | recruiting | — | 25 | Andrés José Maria FerreriOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06941363 | Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence(SUPERB) | recruiting | — | 50 | University of Milano BicoccaOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07344363 | Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoring(PRECISION) | recruiting | — | 100 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Feb 2, 2026 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials